Literatur
Beghi E, Carpio A, Forsgren L et al (2010) Recommendation for a definition of acute symptomatic seizure. Epilepsia 51:671–675
Berg AT, Shinnar S (1991) The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 41:965–972
Fisher RS, Emde BW van, Blume W et al (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472
Gilmore E, Choi HA, Hirsch LJ, Claassen J (2010) Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage. Neurologist 16:165–175
Hauser WA, Rich SS, Lee JR et al (1998) Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 338:429–434
Hesdorffer DC, Benn EK, Cascino GD, Hauser WA (2009) Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 50:1102–1108
King MA, Newton MR, Jackson GD et al (1998) Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 352:1007–1011
Marson A, Jacoby A, Johnson A et al (2005) Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365(9476):2007–2013
Musicco M, Beghi E, Solari A, Viani F (1997) Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 49(4):991–998
Thapa A, Chandra SP, Sinha S et al (2010) Post-traumatic seizures-a prospective study from a tertiary level trauma center in a developing country. Seizure 19:211–216
Interessenkonflikt
H.M. Hamer war Mitglied von Beratungsgremien von cerbomed, Eisai, Desetin, GSK, Pfizer und UCB Pharma und erhielt Rednerhonorare sowie Unterstützung für Forschungsvorhaben und Veranstaltungen von Ad-Tech, Cyberonics, Eisai, Desetin, GSK, NeuroConsil, Nihon Kohden, Novartis, Pfizer, Thieme und UCB Pharma. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dieser Beitrag ist Teil einer Pro-und-Kontra-Debatte. Den zugehörigen Kontra-Standpunkt finden Sie unter http://dx.doi.org/10.1007/s00115-014-4001-2.
Rights and permissions
About this article
Cite this article
Hamer, H. Behandlung nach dem ersten Anfall? Pro. Nervenarzt 85, 757–758 (2014). https://doi.org/10.1007/s00115-014-4002-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-014-4002-1